(Q54267375)

27 May 2018

title

Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma. (English)

1 reference

27 May 2018

1 reference

Jing Cui

1

1 reference

27 May 2018

Yong Yu

2

1 reference

27 May 2018

Gao-Feng Lu

3

1 reference

27 May 2018

Chao Liu

4

1 reference

27 May 2018

Xia Liu

5

1 reference

27 May 2018

Yu-Xian Xu

6

1 reference

27 May 2018

Peng-Yuan Zheng

7

1 reference

27 May 2018

publication date

21 March 2013

1 reference

27 May 2018

published in

Tumor Biology

1 reference

27 May 2018

volume

34

1 reference

27 May 2018

issue

3

1 reference

27 May 2018

page(s)

1913-1918

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1007/s13277-013-0735-x

exact match

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0735-X

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0735-X

Updated treatment approach to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0735-X

Focus on hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0735-X

Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0735-X

ARK5 is a tumor invasion-associated factor downstream of Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0735-X

Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0735-X

Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0735-X

ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0735-X

Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0735-X

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0735-X

Non-Hodgkin lymphoma: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0735-X

Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0735-X

High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23516026

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The Akt and ERK activation by platinum-based chemotherapy in ovarian cancer is associated with favorable patient outcome.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23516026

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-013-0735-X

1 reference

27 May 2018

1 reference

27 May 2018